X-irradiation enhances the expression of Bcl-2 in HL-60 cells: The resulting effects on apoptosis and radiosensitivity

International Journal of Molecular Medicine

Volumn 3, Issue 2, 1999, Pages 145-152

  Kariya, Shinji ^a   Ogawa, Yasuhiro ^b   Yoshida, Shoji ^c   Yabuki, Munehisa ^a   Imajo, Yoshinari ^a   Utsumi, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b University of Tokyo   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Bcl 2; Cell cycle; HL 60 cell; Radiation

Indexed keywords

BAX PROTEIN, HUMAN; DNA FRAGMENT; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN HL 60; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION; HUMAN; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; TIME;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; G1 PHASE; GENE EXPRESSION; HL-60 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; S PHASE; TIME FACTORS;

EID: 0033068790     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.2.145     Document Type: Article

References (40)

1. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556,1980.
2. Lane DP: Cancer. A death in the life of p53. Nature 362: 786-787, 1993.
3. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
4. Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546, 1992.
5. Tsujimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with 'the t(14;18) chromosome translocation. Science 226: 1097-1099, 1984.
6. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
7. Dole M, Nuenz G, Merchant AK, Maybaum J, Rode CK, Bloch CA and Castle VP: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54: 3253-3259,1994.
8. Jacobson MD and Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374: 814-816,1995.
9. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG and Dixit VM: Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-Iike apoptotic proteases. J Biol Chem 271: 4573-4576, 1996.
10. Brady HJ, Salomons GS, Bobeldijk RC and Berns AJ: T cells from bax-alpha transgenic mice show accelerated apoptosis in responce to stimuli but do not show restored DNA damage-induced cell death in the absence of p53 gene product in. EMBO J 15: 1221-1230, 1996.
11. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387: 773-776, 1997.
12. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413, 1997.
13. Mignotte B and Vaysiere JL: Mitochondria and apoptosis. Eur J Biochem 252: 1-15, 1998.
14. Ceretti DP, Kozlosky CJ, Mosley B, Nelson N, Van NK, Greenstreet YA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K and Black RA: Molecular cloning of the interleukin-l beta converting enzyme. Science 256: 97-100, 1992.
15. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston K, Ayala JM, Casano FJ, Chin J, Ding GJF, Eeger LA, Gaddney EP, Limjuco G, Payha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, MaCross M, Mumford RA, Schimidt JA and Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-l beta processing in monocytes. Nature 356: 768-774, 1992.
16. Alnemri ES, Livingston DJ, Nicholson DW, Salvcsen G, Thornberry NA, Wong WW and Wuan J: Human ICE/CED-3 protease nomenclature. Cell 87: 171,1996.
17. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299,1995.
18. Halder S, Negrini M, Monne M, Sabbioni S and Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54: 2095-2097,1994.
19. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sei USA 89: 7491 -7495,1992.
20. Han Z, Chatterjee D, He DM, Elary J, Pantazis P, Wyche JH and Hendrickson A: Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol Cell Biol 15:5849-5857, 1995.
21. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon N Jr, Tatar E, Tung TS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC and Kaupfmann SH: Activation of multiple interleukin-1 beta convering enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 272: 7421-7430, 1997.
22. Wolf D and Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sei USA 82: 790-794,1985.
23. Gavrieli Y, Sherman Y and Ben SS: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992.
24. Sambrook J, Fritsch EF and Maniatis T: Gel electrophoresis of DNA. In: Molecular Cloning, A Laboratory Mannual. 2nd edition. Ford N, Nolan C and Ferguson M (eds). Cold Spring Harbor, New York, pp6.1-6.62, 1987.
25. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
26. Ayala JM, Yamin TT, Egger LA, Chin J, Kostura MJ and Miller DK: IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol 153: 2592-2599, 1994.
27. 2+)-mediated endogenous endonuclease activation in apoptotic thymocytes. J Immunol 155:5133-5139, 1995.
28. Nicholson DM, Ali A, Thomberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
29. Sekine C, Yagita H, Kobata T, Hasunuma T, Nishioka K and Okumura K: Fas-mediated stimulation induces IL-8 secration by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biohem Biophys Res Commun 228: 14-20, 1996.
30. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW and Weichselbaum RR: Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res 55: 991-994, 1995.
31. Abend M, Rhein A, Cilbertz KP, Blakely WF and Van BD: Correlation of micronucleus and apoptosis assays with reproductive cell death. Int J Radiat Biol 67: 315-326, 1995.
32. Hopcia KL, McCarey YL, Sylvester C and Held KD: Radiation-induced apoptosis in HL60 cells: oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose. Radiat Res 145: 315-323, 1996.
33. Hall EJ: Cell survival curves. In: Radiobiology for the Radiologist. 4th edition. J.B. Lippincott Company, Philadelphia pp29-43, 1994.
34. Tepper CG and Studzinski GP: Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res 52: 3384-3390, 1992.
35. Kumakura S, Ishikura H, Tsumura H, Iwata Y, Endo J and Kobayashi S: C-myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF alpha-treated HL-60 cells. Leuk Lymphoma 23: 383-394, 1996.
36. LoennechenT, Moens U, Kildalsen H, Andersen A, Rekvig OP and Aarbakke J: Effects of 3-deazaadenosine on apoptosis-related gene transcripts in HL-60 cells. Pharmacol Toxicol 81: 199-204, 1997.
37. Wiger R, Finstad HS, Hongslo JK, Haug K and Holme JA: Paracetamol inhibits cell cycling and induces apoptosis in HL-60 cells. Pharmacol Toxicol 81: 285-293, 1997.
38. Henriksson M and Luscher B: Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182, 1996.
39. 1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15: 1347-1356, 1997.
40. Ibrado AM, Huang Y, Fang G, Liu L and Bhalla K: Over-expression of Bcl-2 or Bc1-xL inhibits Ara-C-induced CPP32/ yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 56: 4743-4748, 1996.